App-Quantinova.ai

A NOVEL BIOMARKER OF CIRCULATING GLYCOPROTEINS AND CARDIOVASCULAR AND ALL-CAUSE MORTALITY AMONG 39,521 INITIALLY HEALTHY ADULTS

Patrick R. Lawler - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

BENEFICIAL EFFECTS OF BLOOD PRESSURE REDUCTION ON AORTIC STIFFNESS AND CENTRAL HEMODYNAMICS IN PATIENTS WITH METABOLIC SYNDROME

Panagiota Pietri - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

Hydrochlorothiazide

GLYCA, A NOVEL NMR BIOMARKER OF INFLAMMATION, AND INCIDENT CARDIOVASCULAR EVENTS: THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS

Daniel A. Duprez - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Peripheral artery disease

N/A

SHORT-TERM MAGNESIUM OXIDE MONOHYDRATE TREATMENT IMPROVES LIPIDS AND INFLAMMATION IN HEALTHY SUBJECTS

Michael Shechter - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Coronary Artery Disease

N/A

THE PULMONARY VASCULAR RESISTANCE AND PULMONARY VASCULAR RESISTANCE TO SYSTEMIC RESISTANCE RATIO BUT NOT DIASTOLIC PULMONARY GRADIENT, MAY PREDICT SURVIVAL IN PATIENTS WITH PULMONARY HYPERTENSION: INSIGHTS FROM A SINGLE-CENTER STUDY

Cihangir Kaymaz - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

EX VIVO SIMULATION OF THE IMMUNE RESPONSE AGAINST OXDIZED LOW-DENSITY LIPOPROTEIN AS A NEW RISK STRATIFICATION IN CORONARY ARTERY DISEASE

Tomoyuki Honjo - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

ASSOCIATION OF NON-HIGH DENSITY LIPOPROTEIN-CHOLESTEROL WITH CAROTID INTIMA-MEDIA THICKNESS AND CARDIOVASCULAR EVENS IN MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS

Alexandros Briasoulis - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Coronary Artery Disease

N/A

HIGH LEVELS OF FIBRINOGEN, BUT NOT FIBRINOGEN GENETIC VARIANTS PREDICT CORONARY ARTERY DISEASE IN SUBJECTS WITH HYPERTENSION AND DIABETES MELLITUS TYPE 2

Nikolaos Papageorgiou - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Type 2 diabetes mellitus

ILS-969

RISK SCORES AND BIOMARKERS FOR THE PREDICTION OF 1-YEAR OUTCOME AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT

Jan-Malte Sinning - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Myocardial Dysfunction

N/A

INFLAMMATION AND VASCULAR COMPLIANCE MEASUREMENTS: A PARADOX? THE BOGALUSA HEART STUDY

Camilo Fernandez - Alonso - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Systemic inflammation

N/A

EFFECTS OF NEPHRECTOMY ON CARDIOVASCULAR STRUCTURE AND FUNCTION IN LIVING KIDNEY DONORS

William Edward Moody - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Chronic kidney disease

Parathyroid hormone

INCREASED SUPERFICIAL BRIGHT SPOTS AT THE CULPRIT LESION IN PATIENTS WITH ACUTE CORONARY SYNDROME: AN OPTICAL COHERENCE TOMOGRAPHY STUDY

Yoshiyasu Minami - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

PROGNOSTIC UTILITY OF FIBROBLAST GROWTH FACTOR-23 AFTER AN ACUTE CORONARY SYNDROME

Jacob A. Udell - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Acute Coronary Syndromes

Phosphatonin

MYOCARDIAL INJURY DURING ON-PUMP CORONARY ARTERY BYPASS SURGERY

Shirjel Alam - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

Elaszym

THE EFFECT OF MANUAL THROMBUS ASPIRATION OVER ENDOTHELIAL FUNCTION AND INFLAMMATORY MARKERS IN PATIENTS PRESENTING WITH ST-ELEVATION MYOCARDIAL INFARCTION

Sadik Acikel - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

ILS-969

HIGH SENSITIVITY C REACTIVE PROTEIN IS AN INDEPENDENT MARKER OF CORONARY ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH NONOBSTRUCTIVE CORONARY ARTERY DISEASE

Jaskanwal Deep Sara - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Acetylcholine

INTERLEUKIN-6 AND THE RISK OF ADVERSE OUTCOMES IN PATIENTS AFTER AN ACUTE CORONARY SYNDROME: OBSERVATIONS FROM THE SOLID-TIMI 52 TRIAL

Christina Fanola - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Acute Coronary Syndromes

ILS-969

GLOBAL LONGITUDINAL STRAIN IS A PREDICTOR OF HEART FAILURE IN PATIENTS WITH ACUTE ANTERIOR WALL MYOCARDIAL INFARCTION

Sun-Hwa Lee - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

PREGNANCY-ASSOCIATED PLASMA PROTEIN-A PREDICTS ADVERSE CARDIOVASCULAR OUTCOMES 2 YEARS POST ACUTE CORONARY SYNDROME IN PATIENTS WITH AND WITHOUT TYPE-2 DIABETES MELLITUS

Xue Qiao Zhao - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

SYSTEMIC INFLAMMATION IS ASSOCIATED WITH CORONARY ARTERY CALCIFICATION AND ALL-CAUSE MORTALITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE

In-Chang Hwang - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Complex calcified coronary artery lesions

N/A

Filters

1408 Abstracts